Close Menu
    What's Hot

    Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

    August 17, 2026

    Athora To Sell German Business to Frankfurter Leben

    August 17, 2026

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 17, 2026

      Athora To Sell German Business to Frankfurter Leben

      August 17, 2026

      Talcott Financial Group, Goldman Sachs Launch West Grove Re

      August 5, 2026

      Lincoln Financial Reinsures Universal Life Block With Talcott

      August 3, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

      August 12, 2026

      Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      August 5, 2026

      Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 3, 2026

      UK Insurance Company Pension Scheme Completes Bulk Purchase Annuity Transaction With M&G

      August 3, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

      August 6, 2026

      Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 17, 2026

      Athora To Sell German Business to Frankfurter Leben

      August 17, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: Carl Groth, Chief Risk Officer, Legal and General Retirement America

    Longevity and Mortality Risk Transfer August 13, 2025By Greg Winterton
    Share
    Twitter LinkedIn Email

    Total US pension risk transfer (PRT) new premium was $7.1bn in the first quarter of 2025, according to LIMRA’s U.S. Group Annuity Risk Transfer Sales Survey. While this is 51% lower than the record-high sales set in the first quarter of 2024, at 127 contracts, the market contracted only 13% from prior year. Greg Winterton caught up with Carl Groth, Chief Risk Officer at Legal & General Retirement America, to get his thoughts on the state of the market as we enter H2. 

    GW: Carl, pension risk transfer activity in the US so far this year is down when compared to 2024. What have been the main drivers of the pullback? 

    CG: One driver is a reduction in the jumbo (multi-billion) deals throughout the first half of the year. These big deals can drive up market volumes considerably and reduce volumes when they do not go to market. We saw fewer jumbo deals in the first half of this year compared to last year. However, the market for non-jumbo deals looks to be picking up as we are starting the second half of 2025. 

    GW: How do you assess and manage the long-term liabilities associated with pension risk transfer deals, especially in an interest rate and mortality environment that is arguably unclear at present? 

    CG: I will address mortality first. We devote considerable resources to the science of mortality. For example, we study the uptake and impact of new drugs, such as semaglutides and trends in various forms of disease across demographic groups. This effort helps us calibrate longevity trend factors used in our pricing. Additionally, we use a multifactor model to predict longevity and update the model regularly. The size of our PRT back book is considerable and enables us to back test actual results against pricing assumptions and make any necessary adjustments.  

    Management of interest rates is primarily done through ALM – matching asset duration or cash flows to the liability asset duration or cash flow depending on the size of the business and the regulatory requirements. We run sensitivities and stresses to get comfortable with the ability to stay reasonably matched. 

    GW: What trends are you observing in plan sponsor behaviour, and how are those trends shaping insurer appetite or approach to PRT transactions? 

    CG: In general, plan sponsors remain keen to derisk. The derisking process often takes several years and as such, can be temporarily interrupted by more pressing business issues. An example of a pressing business issue that is affecting some plan sponsors this year is assessing the potential impact of tariffs on their business. This issue can take time away from the same individuals that might be involved with taking a case to market (e.g. the Finance function). 

    GW: What are the key operational and counterparty risks in executing and managing large PRT deals, and how do you oversee them at the enterprise level? 

    CG: For insurers that also provide the administration for their annuitants, that implicitly involves operational risk throughout the life of a deal. Other operational risks might include model or human errors in pricing, information security risk, and risks inherent in the investment management process. In our case, counterparty risks in the traditional sense, are limited to a relatively small amount of reinsurance and or partnering on deals.  

    These risks are overseen at various levels, beginning with the first line of defence that provides a solid foundation for risk oversight. Each entity and major business within each entity should also have its own risk committee, with risk committees at the group level as well. 

    GW: Lastly, Carl, how do you see the US PRT market evolving over the next three to five years, and what are the main strategic or systemic risks you think the industry should be preparing for? 

    CG: I see the US PRT market continuing to flourish over this time horizon and expect market volumes to be driven by the presence or absence of the multi-billion dollar deals as mentioned earlier. One area that I would highlight is the growing number of competitors in the space. There are currently over 20 insurers active in the PRT market and high demand from plan sponsors. While this increased activity brings innovation and choices to plan sponsors, it also means careful attention must be paid to pricing discipline and risk management. Ultimately, I believe market dynamics and responsible management will foster continued growth. 

    Carl Groth is Chief Risk Officer at Legal and General Retirement America 

    2025 - August Longevity Risk Pension Risk Transfer Q&A Volume 4 Issue 8 – August 2025
    Share. Twitter LinkedIn Email

    Related Posts

    Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

    August 17, 2026By LMI Newsdesk

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026By Greg Winterton

    Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

    August 5, 2026By LMI Newsdesk

    Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

    August 3, 2026By LMI Newsdesk
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.